Environmental

R&D intensity of 4.8% of revenue suggests some product-development efficiency, but peer-relative environmental disclosure remains limited versus larger medtech peers.

Debt-to-equity of 0.57 indicates moderate balance-sheet leverage, which can constrain capital available for environmental upgrades compared with lower-levered peers.

Net debt to EBITDA of 6.35 implies elevated financing rigidity, making sustained investment in energy, waste, and compliance initiatives less flexible than peers.

No filing-based evidence provided on emissions, energy use, or waste management, so environmental positioning cannot be confirmed as stronger than peer norms.

Social

Gross margin of 65.3% supports some capacity to fund workforce, training, and product-quality programs, but this is not enough to establish peer-leading social positioning.

Stock-based compensation of 3.3% of revenue suggests employee-alignment incentives, yet peer comparison is unclear without broader disclosure on retention and safety metrics.

No filing-based evidence provided on patient safety, product quality, labor practices, or community impact, limiting confidence that social risk management exceeds peers.

The available metrics indicate operational discipline, but social performance remains only moderately positioned relative to peers because core human-capital disclosures are absent.

Governance

Stock-based compensation at 3.3% of revenue is manageable, but peer-relative governance strength cannot be confirmed without board, pay, and ownership disclosures.

Debt-to-equity of 0.57 suggests moderate leverage, which is less governance-stretching than highly levered peers but still requires disciplined oversight.

Net debt to EBITDA of 6.35 raises refinancing sensitivity, increasing governance importance around capital allocation and covenant management versus less levered peers.

No filing-based evidence provided on board independence, audit quality, or shareholder rights, so governance appears adequate but not demonstrably superior to peers.

Overall Score

ZIMV appears moderately positioned versus peers overall, with acceptable capital discipline offset by limited disclosure and leverage-related constraints across ESG dimensions.

Score Driver: Elevated Leverage And Incomplete ESG Disclosure Limit Peer-Relative Strength.